Literature DB >> 26756084

Fetal cerebro-placental ratio and adverse perinatal outcome: systematic review and meta-analysis of the association and diagnostic performance.

Ahmed Abobakr Nassr, Ahmed M Abdelmagied, Sherif A M Shazly.   

Abstract

OBJECTIVE: The objective of this meta-analysis is to assess the value of fetal cerebro-placental Doppler ratio (CPR) in predicting adverse perinatal outcome in pregnancies with fetal growth restriction (FGR).
METHODS: Three databases were used: MEDLINE, EMBASE (with online Ovid interface) and SCOPUS and studies from inception to April 2015 were included. Studies that reported perinatal outcomes of fetuses at risk of FGR or sonographically diagnosed FGR that were evaluated with CPR were considered eligible. Perinatal outcomes include cesarean section (CS) for fetal distress, APGAR scores at 5 min, neonatal complications and admission to neonatal intensive care unit (NICU). Pooled data were expressed as odds ratio (OR) and confidence intervals (CI), and the summary receiver operating characteristic (SROC) curve was used to illustrate the diagnostic accuracy of CPR.
RESULTS: Seven studies were eligible (1428 fetuses). Fetuses with abnormal CPR were at higher risk of CS for fetal distress (OR=4.49, 95% CI [1.63, 12.42]), lower APGAR scores (OR=4.01, 95% CI [2.65, 6.08]), admission to NICU (OR=9.65, 95% CI [3.02, 30.85]), and neonatal complications (OR=11.00, 95% [3.64, 15.37]) than fetuses who had normal CPR. These risks were higher among studies that included fetuses diagnosed with FGR than fetuses at risk of FGR. Abnormal CPR had higher diagnostic accuracy for adverse perinatal outcomes among "sonographically diagnosed FGR" studies than "at risk of FGR" studies.
CONCLUSION: Abnormal CPR is associated with substantial risk of adverse perinatal outcomes. The test seems to be particularly useful for follow up of fetuses with sonographically diagnosed FGR.

Mesh:

Year:  2016        PMID: 26756084     DOI: 10.1515/jpm-2015-0274

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  6 in total

Review 1.  Systematic review evaluating the efficacy of the cerebroplacental ratio (CPR) in saving babies lives.

Authors:  Catherine Elmes; Rita Phillips
Journal:  Ultrasound       Date:  2021-10-19

Review 2.  Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis.

Authors:  C A Vollgraff Heidweiller-Schreurs; M A De Boer; M W Heymans; L J Schoonmade; P M M Bossuyt; B W J Mol; C J M De Groot; C J Bax
Journal:  Ultrasound Obstet Gynecol       Date:  2018-02-05       Impact factor: 7.299

3.  Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy (RATIO37): randomised controlled trial study protocol.

Authors:  Francesc Figueras; Eduard Gratacos; Marta Rial; Ilan Gull; Ladislav Krofta; Marek Lubusky; Rogelio Cruz-Martinez; Mónica Cruz-Lemini; Miguel Martinez-Rodriguez; Pamela Socias; Cristina Aleuanlli; Mauro C Parra Cordero
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

4.  The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants.

Authors:  Lisa Middendorf; Alexandra Gellhaus; Antonella Iannaccone; Angela Köninger; Anne-Kathrin Dathe; Ivo Bendix; Beatrix Reisch; Ursula Felderhoff-Mueser; Britta Huening
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

5.  Third-trimester Reference Ranges for Cerebroplacental Ratio and Pulsatility Index for Middle Cerebral Artery and Umbilical Artery in Normal-growth Singleton Fetuses in the Israeli Population.

Authors:  Efraim Zohav; Eyal Zohav; Mark Rabinovich; Ahmad Alasbah; Simon Shenhav; Hadar Sofer; Yaniv S Ovadia; Eyal Y Anteby; Leonti Grin
Journal:  Rambam Maimonides Med J       Date:  2019-10-29

6.  Cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis of individual participant data.

Authors:  C A Vollgraff Heidweiller-Schreurs; I R van Osch; M W Heymans; W Ganzevoort; L J Schoonmade; C J Bax; Bwj Mol; Cjm de Groot; Pmm Bossuyt; M A de Boer
Journal:  BJOG       Date:  2020-06-08       Impact factor: 7.331

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.